1-3 of 3
Jessica Meikle
Close
Sort by
Journal Articles

Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma

Clinical Trials & Observations Brief Report
Craig S. Sauter, Matthew J. Matasar, Jessica Meikle, Heiko Schoder, Gary A. Ulaner, Jocelyn C. Migliacci, Patrick Hilden, Sean M. Devlin, Andrew D. Zelenetz, Craig H. Moskowitz
Journal: Blood
Blood (2015) 125 (16): 2579–2581.
https://doi.org/10.1182/blood-2014-10-606939
Published: 2015
Journal Articles

Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

Craig Moskowitz, MD, Paul A Hamlin, Jr., Jocelyn Maragulia, Jessica Meikle, Andrew D Zelenetz, MD
Journal: Blood
Blood (2010) 116 (21): 420.
https://doi.org/10.1182/blood.V116.21.420.420
Published: 2010
Journal Articles

Bendamustine Is Highly Active in Heavily Pre-Treated Relapsed and Refractory Hodgkin Lymphoma and Serves as a Bridge to Allogeneic Stem Cell Transplant.

Alison J. Moskowitz, MD, Paul A. Hamlin, Jr., MD, John Gerecitano, MD, PhD, Steven M. Horwitz, MD, Matthew Matasar, MD, Jessica Meikle, Ariela Noy, MD, Maria Lia Palomba, MD, Carol S. Portlock, MD, David J. Straus, MD, Jill M Vanak, ACNP, Andrew D. Zelenetz, MD, PhD, Craig H Moskowitz, MD
Journal: Blood
Blood (2009) 114 (22): 720.
https://doi.org/10.1182/blood.V114.22.720.720
Published: 2009